Geroscience Course (R25 Independent Clinical Trial Not Allowed) | PAR 22 214

Opportunity Information: Apply for PAR 22 214

The Geroscience Course (R25 Independent Clinical Trial Not Allowed) funding opportunity (PAR-22-214) is a National Institutes of Health (NIH) discretionary grant program designed to strengthen education and workforce development in geroscience. Its central aim is to support educational activities that complement and expand the training of both the clinical and research workforce while also increasing public awareness of geroscience. The program emphasizes creative, well-integrated learning efforts that connect basic biology of aging with applied, translational, and clinical perspectives, helping learners and stakeholders understand how aging biology relates to chronic disease risk, resilience, functional decline, and opportunities for prevention or intervention across the lifespan.

Projects supported under this opportunity are expected to focus on educational development rather than conducting independent clinical trials. The scope is intentionally broad in terms of educational format, encouraging applicants to develop and integrate geroscience content through several allowable activity types. These include curriculum or methods development (for example, creating new teaching modules, case-based learning materials, or training approaches that bridge laboratory discoveries to clinical questions), courses for skills development (such as short courses, workshops, boot camps, or structured training programs aimed at building geroscience-relevant competencies), and research experiences and networking (which might include mentored research exposure, career development-oriented experiences, or structured networking that builds cross-disciplinary collaboration). The opportunity also supports creating shared knowledge resources, such as developing a repository of key reviews, opinion pieces, and information on clinical trials in progress in geroscience-related areas, as well as outreach efforts and the production of lay public documents that translate geroscience concepts into accessible language for non-specialist audiences.

Eligibility is expansive and includes a wide range of U.S.-based organizations and governmental entities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; other Native American tribal organizations (other than federally recognized tribal governments); public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding institutions of higher education when specified in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other applicant types as permitted by NIH. The announcement explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions, signaling an interest in broad participation and potentially wide dissemination of geroscience education.

Foreign eligibility is limited. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the primary applicant organization, and non-domestic components of U.S. organizations are also not eligible. However, foreign components, as defined by the NIH Grants Policy Statement, are allowed, meaning a U.S. applicant may include certain foreign collaborations or elements when they are justified and meet NIH policy requirements.

From an administrative and funding standpoint, this opportunity is categorized as a grant in the health funding activity area, associated with CFDA number 93.866. The source data lists an award ceiling of $250,000 and indicates an original closing date of October 21, 2022, with a creation date of July 27, 2022. Overall, the program is geared toward building geroscience capacity through structured education, training, resource development, and public-facing communication, with the explicit constraint that it is not meant to support independent clinical trial activity.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Geroscience Course (R25 Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
• This funding opportunity was created on 2022-07-27.
• Applicants must submit their applications by 2022-10-21. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $250,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 22 214

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: